Literature DB >> 2544587

Characterization of the promoter region of the human thrombospondin gene. DNA sequences within the first intron increase transcription.

C D Laherty1, T M Gierman, V M Dixit.   

Abstract

Thrombospondin (TSP) is an extracellular matrix glycoprotein whose synthesis and secretion by mesenchymal cells is regulated at the level of gene transcription by platelet-derived growth factor. To examine the transcriptional regulation of the TSP gene at the molecular level, a genomic clone containing the human TSP promoter and flanking sequence was isolated and characterized. A 3.8-kilobase pair (kb) DNA fragment containing the first three exons, the first two introns, and 2.2 kb of 5'-flanking region was sequenced, and the site of transcription initiation was determined by both primer extension and S1 nuclease mapping. Consensus sequences for several potential regulatory elements were found in the 5'-flanking sequence, including a TATA box consensus sequence, TTTAAAA, located 24 base pairs upstream from the transcription start site. A chimeric gene was constructed containing the first intron, the first exon, and 2.0 kb of 5'-flanking sequence of the TSP gene fused to the promoterless gene for chloramphenicol acetyltransferase. When transfected into COS-1 or NIH3T3 cells this gene construct was transcribed, indicating the presence of a functional promoter in the TSP sequence. Transient transfection studies using deletion mutants of this TSP-chloramphenicol acetyltransferase construct were performed to locate cis-acting regulatory sequences. The deletion of flanking sequence 5' to position -234 had little or no effect on transcriptional activity, whereas deletion of 5'-flanking sequence extending further in the 3' direction resulted in the gradual loss of transcriptional activity. The removal of the first intron resulted in a 4-fold decrease in transcript levels, indicating the presence of a cis-acting positive element(s) in the first intron of the human TSP gene. This element(s) was further localized to the region between position +576 and position +727.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544587

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  Thrombospondin as a mediator of cancer cell adhesion in metastasis.

Authors:  D A Walz
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

2.  Identification and characterization of the promoter for the cytotactin gene.

Authors:  F S Jones; K L Crossin; B A Cunningham; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Homology between alpha 2(V) and alpha 1(III) collagen promoters and evidence for negatively acting elements in the alpha 2(V) first intron and 5' flanking sequences.

Authors:  D S Greenspan; S T Lee; B S Lee; G G Hoffman
Journal:  Gene Expr       Date:  1991-04

4.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

5.  Activation of the myc oncoprotein leads to increased turnover of thrombospondin-1 mRNA.

Authors:  A Janz; C Sevignani; K Kenyon; C V Ngo; A Thomas-Tikhonenko
Journal:  Nucleic Acids Res       Date:  2000-06-01       Impact factor: 16.971

6.  Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53.

Authors:  J Cinatl; R Kotchetkov; M Scholz; J Cinatl; J U Vogel; P H Driever; H W Doerr
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

7.  Thrombospondin 1 acts as a strong promoter of transforming growth factor beta effects via two distinct mechanisms in hepatic stellate cells.

Authors:  K Breitkopf; I Sawitza; J H Westhoff; L Wickert; S Dooley; A M Gressner
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

8.  Loss-of-function thrombospondin-1 mutations in familial pulmonary hypertension.

Authors:  James P Maloney; Robert S Stearman; Todd M Bull; David W Calabrese; Megan L Tripp-Addison; Marilee J Wick; Ulrich Broeckel; Ivan M Robbins; Lisa A Wheeler; Joy D Cogan; James E Loyd
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-23       Impact factor: 5.464

Review 9.  Invoking the power of thrombospondins: regulation of thrombospondins expression.

Authors:  Olga Stenina-Adognravi
Journal:  Matrix Biol       Date:  2014-02-25       Impact factor: 11.583

10.  A second thrombospondin gene in the mouse is similar in organization to thrombospondin 1 but does not respond to serum.

Authors:  P Bornstein; S Devarayalu; P Li; C M Disteche; P Framson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.